Abstract: Pharmacological, derivate and microbiological study of beebread based immunomodulatory drug was conducted. Iimmunomodulating properties of pellets "Apimun" in the form of antibodies formation in response to the EB antigen were studied. Clear immunostimulatory properties of pellets "Apimun" were reproduced in mature rats and mice with normal immune status. Pellets "Apimun" at doses 1.5 and 2.0 g/kg showed increased activity of phagocytosis and processes of antibody formation inhibition of delayed hypersensitivity reactions. Antimicrobial activity of pellets "Apimun" was studied. It was proved that it did not have antimicrobial properties. Derivate studies were conducted and showed that the active substance and composition of the IMP was stable at normal temperature. The results of pharmacological, microbiological and derivate studies show the effectiveness of the pellets "Apimun" and prospects for further research in order to create a product for immune status improvement.
Introduction


Provision of an adequate level of immunoprotection which, along with nervous and hormone systems, ensures the smooth functioning of the human body is one of the most essential elements in human health.
Today, the human immune system is exposed to extreme loads caused by environmental pollution, ionizing radiation, effects of the Chernobyl accident, AIDS pandemic, etc., that's why it requires maximum and all-out support. These factors and other crises including one more significant destructive factor, namely stress, have pathogenic effect on the immune system. The pathogenic role of stress increases several times if the immune system is simultaneously exposed to HIV, radiation, and radionuclides of food, thus forcing people to live in extremely harsh living conditions without rational social and medical orientation. The things specified above underline the usefulness and importance of developing efficient immunostimulatory drugs.
Despite the sufficiently broad range of immunostimulatory drugs, most of them are synthetic drugs (levamisole, T-atkyvin, tymalin, etc.). The use of the latter can lead to exhaustion of the immune system due to an excessive intrusion into its function. Thus, the development of immunomodulatory drugs having a mild and natural effect on the human body remains an important problem of modern medicine and pharmacy.
Of particular interest to this matter are standardized drugs of natural origin made on the basis of bee products which differ favorably from synthetic immunistimulators by a biological interaction with tissues of the body. These drugs become more and
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more popular in the market of pharmaceutical drugs [1, 2] . It is known that the use of drugs of natural and plant origin is related mainly to their high biological activity, bioavailability and efficiency of the therapeutic effect. The majority of natural chemical compounds are less toxic for human body than their synthetic analogues or original chemical substances. This in its turn is an opportunity to use it for a long period of time during the treatment of chronic diseases or for prophylactic purposes against different diseases.
The significant feature of drugs made of natural raw materials is their ability to activate immune defenses, promote adaptive processes, and increase the immunoreactivity of the body.
The present work deals with the pharmacological and microbiological study of a new immunotropic drug made on the basis of bee products, namely the "Apimun" bee bread granules, as well as with the study of chemical and physiochemical processes that occur under changing temperature conditions (thermogram).
The present article contains the results of pharmacological, microbiological and derivatographic studies of the "Apimun" bee bread granules, as follows:
Study of the effect of the "Apimun" bee bread granules on blood neutrophil phagocytic activity of mature rats;
Study of the effect of the "Apimun" bee bread granules on indicators of the immune system of mature rats having a satisfactory immune status;
On mass coefficients of immunocompetent organs (spleen and thymus) of mice;
On the processes of formation of antibodies by an overall number of antibody-producing cells in spleen, and hemagglutinin titers in blood serum of rats;
Study of the effect of the "Apimun" bee bread granules on the development of DHR (delayed hypersensibility reaction);
Study of the antimicrobial activity of test samples of the "Apimun" granules; Study of chemical and physiochemical processes occurring in drug samples under changing temperature conditions.
Materials and Methods
During the experiment, the animals were kept in a vivarium at the temperature of 18-24 degrees Celsius, at the humidity level of 50%-60%, under the natural day/night light regime, in plastic cages, maintaining a balanced diet in accordance with the requirements of applicable legislation. The studies have been conducted in compliance with the principles laid down in the European Convention for the Protection of Vertebrate Animals kept for Experimental and other Scientific Purposes.
In the first stage of the experiment, we have verified the effect of immunotropic properties of "Apimun" granules on PAN (phagocytic activity of neutrophils). Study procedure: 0.3% yeast suspension was added to the heparinized venous blood taken from the tail of rats (0.1 mL) and incubated in thermostat at 37 degrees Celsius for 30 minutes. Upon completion of the incubation period, we prepared the smears using slides. The smears were stained by the Romanowsky-Giemsa procedure and studied under the microscope in immersion conditions.
The intensity of phagocytic activity of neutrophils has been estimated by the following indicators: FI (phagocytic index)-percentage of phagocytes per 100 cells, FU (phagocytic number)-average number of yeast cells absorbed by one neutrophil [5, 6] .
We have used the following groups of animals, 5 in each group: 1st group-intact animals; 2-4 groups-animals that have been having intragastric injections of "Apimun" granules at the doses of 0.75, 1.0 and 2.0 g/kg for 4 days.
In the second stage of the experiment, we have studied the effect of "Apimun" granules on humoral immunity of mice. Fluid extract of Echinacea has been used as a reference drug, since it has similar
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pharmacological effect. According to the literature data and our own studies, Echinacea has strong immunotropic properties [2] [3] [4] . A dose of Echinacea extract has been previously determined in experimental studies [3, 4] . We have used the following groups of animals, 8 in each group: 1st group-immunized control; 2-4 groups-animals that have been having intragastric injections of "Apimun" granules at the doses of 0.75, 1.0 and 2.0 g/kg for 4 days prior to the immunization and during the whole immunization period.
To determine the number of APC (antibody-producing cells) and HG (hemagglutinins), the mice have been immunized by a single abdominal injection of 3% suspension of SRBC (sheep red blood cells) at the dose of 0.2 mL/20 g of the animal body mass. On the fifth day after immunization, we have determined a number of antibody-producing cells in spleen and hemagglutinin titers in blood serum.
The determination of the number of APCs has been performed with the help of the hemolysis-in-gel method. This method is based on the ability of lymphoid cells of experimental animals immunized by xenogeneic erythrocytes to release anti-red-cell antibodies that cause the lysis of erythrocytes in the presence of complement [5] [6] [7] [8] . A number of antibody producers per a lymphoid organ have been calculated by the number of hemolysis zones visible under the microscope located near antibody-producing cells.
The HG (hemagglutinin) titers in blood serum of the immunized animals have been determined by a method of serial dilutions in polystyrene titer plates. The agglutination reaction is based on the ability of antibodies (agglutinins) found in blood serum of immunized animals to agglutinate sheep RBCs in isotonic sodium chloride solution that are used as an antigen [5] [6] [7] [8] .
As we use the drug, we have been determining the cell-bound immunity status on the basis of the DHR (delayed hypersensibility reaction) by method of K.P. Kitamura [5, 9] . The reaction is aimed to determine the ability of the investigational drug to affect the production of mediators by sensitized T-lymphocyte effectors that cause tissue infiltration by cell elements. The injection of an antigen into the foot pads of animals causes the development of a localized inflammatory response.
We have used the following groups of animals, 8 in each group-1st group-intact, nonimmunized animals that have not been subjected to any influence; 2nd group-SRBC-immunized animals; 3-5 groups-the animals that have been having intragastric injections of "Apimun" granules at the doses of 0.75, 1.0 and 2.0 g/kg for 4 days prior to the immunization and during the whole immunization period.
The rats have been immunized by a single abdominal injection of SRBC suspension at the dose 
Results and Discussion
The Results of Studies on Pharmacological Activity of "Apimun" Granules
The studies have shown that previous injections of "Apimun" granules during 9 days have caused the increase of phagocytic activity of neutrophils in blood of rats. The significant increase of FI (phagocytic index) has been observed under the influence of the drug injected at the dose of 1.5 and 2.0 g/kg. The identified differences are relevant for the intact control group and indicate the activation of phagocytic activity of neutrophils in blood, namely its absorption function.
The use of the drug at the dose of 0.75 g/kg has not caused the activation of phagocytic function of neutrophils in blood of rats (Table 1) 
Effect of "Apimun" Granules on Humoral Immune Response of Mice with Satisfactory Immune Status
The data of Table 2 show that the injection of the investigational drug during 9 days has caused an increase in the numbers of both antibody-producing cells and hemagglutinin titers ( Table 2 ). At that, the Echinacea extract, 1 mL/kg 8 4115.6  535.5* 10.5 (5.0; 13)* 1. *-differences that are significant for values of the immunized control group, P < 0.05; 2. #-differences that are significant for the reference drug, namely the Echinacea extract, P < 0.05; 3. n-number of animals in the group.
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higher the dose, the better the effect. That testifies to the dose-dependent effect of the drug. It should be noted that "Apimun" granules have outperformed the reference drug, namely the Echinacea extract, in its ability to increase the number of APCs, despite the fact that Echinacea injections have also resulted in a significant increase in the numbers of antibody-producing cells and hemagglutinin titers.
The determination of mass coefficients of immunogenesis organs has shown that a specific mass of the mouse spleen has almost doubled during the immunization of animals by the SRBC antigen (Table  3) .
A splenic mass increases due to activation of immunogenesis processes which are activated as soon as an antigen enters the animal body. Under the influence of "Apimun" granules, the mass of spleen and thymus remains the same, which testifies to the physiological processes that take place in the animal body during SRBC immunization (Table 3) .
By analyzing the data received, it can be concluded that the injection of "Apimun" granules into mice with satisfactory immune status intensifies the processes of antibody genesis. The drug is most effective if injected at the dose of 1.5 g/kg. Such a dose significantly outperforms the ability of the reference drug to stimulate the formation of APCs.
Effect of "Apimun" Granules on Cell-Mediated Immune Response of Mice
According to the data received (Table 4) , the injection of SRBC antigen into the foot pad of immunized mice has caused the development of a localized inflammatory response, as evidenced by a significant threefold increase of the DHR index in comparison with the intact control. At the same time, a significant RI decrease has been found in the animals that have been having intragastric injections of "Apimun" granules at the doses of 0.75, and 1.5 g/kg for 9 days as compared with the animals of the immune control group. That testifies to the ability of the drug to suppress the development of the delayed hypersensibility reaction. The increase of the drug dose up to 2.0 g/kg has led to a weakening of the suppressing effect: the reaction index in this group of animals has not differed significantly from the reaction Table 3 Effect of "Apimun" granules on a MC (molecular complex) of spleen and thymus of mice. 22  0.15 1. *-differences that are significant for values of the intact control group, P < 0.05; 2. **-differences that are significant for values of the confirmatory pathology group, if P < 0.05; 3. n-number of animals in the group. Table 4 Effect of "Apimun" granules on a cellular component of the immune system of mice (n=8).
Animal groups
Reaction index Intact control 3.1 (1.3; 5.5) Immunized control (SRBC) 9.3 (6.3; 11.6)* "Apimun" granules, 0.75 g/kg 3.3 (0.6; 6.0)** "Apimun" granules, 1.5 g/kg 3.0 (1.2; 5.5)** "Apimun" granules, 2.0 g/kg 7.0 (2.3; 16.7) 1. *-significantly different values of the intact control group, P < 0.05; 2. **-significantly different values of the immunized control group, if P < 0.05. (Table 4) . Thus, the studies have shown that "Apimun" granules stimulate the production of antibodies in response to the injection of SRBC antigen and suppress the development of the delayed hypersensibility reaction of mice with a satisfactory immune status. The "Apimun" granules are most effective if injected at the dose of 1.5 g/kg.
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Determination of Antimicrobial Activity
The agar diffusion method ("well diffusion" method) has been used to determine the antimicrobial activity. A set of reference bacterial strains: S. aureus ATCC 6538, E. coli ATCC 25922, P. aeruginosa ATCC 9027, B. subtilis ATCC 6633, C. albicans 885633. The results are shown in the table.
The studies have shown that test samples do not have antimicrobial activity in relation to the gram positive (S. aureus, B. subtilis), gram negative (E. coli, P. aeruginosa) bacteria, and fungi of Candida type.
Study of Chemical and Physiochemical Processes That Occur under Changing Temperature Conditions
When we develop a pharmaceutical drug, there is always a possibility of chemical interaction between active and auxiliary substances of a multi-component drug. We have chosen a derivatographic analysis as one of the thermal methods in the study of the existence or absence of a chemical interaction between the substances and in the study of setting the decomposition temperature of substances that makes it possible to simultaneously register the mass change by a sample and register the processes that are accompanied by the production or absorption of heat [12] . The studies have been conducted with the help of the Derivatograph Q-1500D device.
According to the data of Fig. 1 , the substance (bee bread) was stable under the temperature of 37 degrees of Celsius. Upon further heating, until the temperature reached 116 degrees of Celsius, the mass loss was ∆m = 7% of the batch m н = 200 g. The maximum disintegration rate of the substance started at 68 °С, where ∆m = 3.5%. When we fried the substance at the temperature up to 500 °С, the exothermic reaction could already be observed at 270 °С. A maximum disintegration of the bee bread took place at 320 °С. At the temperature of up to 380 °С, the mass loss was ∆m = 68% of the batch Al 2 O 3 . Fig. 2 shows that the release of substances from the "Apimun" granules starts at 29 degrees Celsius. At the temperature of up to 108 °С, the mass loss was ∆m = 7.5% of the batch m н = 200 g. Upon further frying up to 500 °С, there were two reactions that released substances with maximum disintegration rates under the temperatures of 220 and 340 degrees Celsius. The other reaction is accompanied by the possibility to express exothermic reactions of the loss of mass. The study showed that the mass loss was ∆m 1 = 29% and ∆m 2 = 40%.
Conclusions
Thus, the results of the study show that "Apimun" granules have stimulating effect on the production of antibodies in response to the injection of SRBC antigen. "Apimun" granules show immunostimulatory effect on mature rats and mice with a satisfactory immune status. If the drug is used at the doses of 1.5 and 2.0 g/kg, "Apimun" granules increase the activity of phagocytosis, intensify the processes of antibody genesis and suppress the development of the delayed hypersensibility reaction.
The studies of antimicrobial activity of "Apimun" granules prove that the drug does not have antimicrobial properties.
The derivatographic studies show that an active substance of the investigational drug and its formula are stable under normal temperature conditions. Thus, the results of pharmacological, microbiological and derivatographic studies testify to the efficiency of "Apimun" granules and potential for further studies in order to develop the drug that would correct an immune status.
